Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation.
about
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Immune activation and inflammation in HIV-1 infection: causes and consequencesOlder age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapyImmune activation and paediatric HIV-1 disease outcomeLarge scale studies assessing anti-factor VIII antibody development in previously untreated haemophilia A: what has been learned, what to believe and how to learn more.Age-specific back-projection of HIV diagnosis data.Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more.Time scales of CD4+ T cell depletion in HIV infection.Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis.Progression of HIV in haemophilia.Joint estimation of CD4+ cell progression and survival in untreated individuals with HIV-1 infection.HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data.The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairment.Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection.Anti-retroviral treatment outcomes among older adults in Zomba district, Malawi.Antiretroviral therapy for human immunodeficiency virus infection in 1997.Treatment of haemophilia in the United Kingdom 1981-1996.Reproductive choices for couples with haemophilia.A challenge for the future: aging and HIV infection.Injecting drug use is associated with a more rapid CD4 cell decline among treatment naïve HIV-positive patients in Indonesia.Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugsCD4+ T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy.Predictors of disease progression in HIV infection: a review.HIV and aging: implications for patient management.Pharmacologic consideration for the use of antiretroviral agents in the elderly.Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database.The impact of HIV infection on adult mortality in some communities in Zambia: a cohort study.Traditional Chinese medicine could increase the survival of people living with HIV in rural central China: a retrospective cohort study, 2004-2012.Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses.Cost-effectiveness analysis of alternative factor VIII products in treatment of haemophilia A.Risk Factors for Early Mortality on Antiretroviral Treatment of Elderly People Infected with HIV in Burkina Faso.Frequency of HLA-A 03 associates with HIV-1 infection in a Chinese cohort.Periodontitis lesions are a source of salivary cytomegalovirus and Epstein-Barr virus.HLA antigens as predictors of disease progression in HIV-infected haemophilia patients (a 22 years' follow up).Causes of death in Canadians with haemophilia 1980-1995. Association of Hemophilia Clinic Directors of Canada.Progression of HIV infection and mortality by hepatitis C infection in patients with haemophilia over 20 years.Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States.Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.Gender difference in HIV-1 RNA viral loads
P2860
Q21034169-21CA3D93-F33F-4701-BF18-D606D825521CQ22252860-68A8C772-F3D1-4CBB-837D-000A520FC662Q24798930-871B8658-7B41-4E43-97E5-191BE0AA4C95Q28086888-AAF4B46F-55C5-4616-8269-AC8E20EB703EQ30234910-35F25711-7AF9-4AB8-8785-809D10532C02Q30805814-7A13AFEF-5611-4D54-A949-FE9F07DCE821Q33262818-356B3614-1ED6-4F08-B068-B3E63AB39D56Q33285395-2DC04BFD-98E0-4951-9F68-294DA7B73D37Q33324733-76AD5E47-4BC4-49F3-A94B-FC3C8022CA1DQ33504805-30018F81-96A1-48E6-85BE-20DAAF818104Q33631159-1C8C83BD-477E-4E6B-98B5-9F7CF3D0F5DEQ33746432-BE97BD35-43D3-4179-A207-1089E814B3C1Q33813372-A7D69D21-89FB-475A-B2FC-CBE6B398B058Q33813926-2A32C905-2410-4746-9712-59883937A113Q34059653-FEB62D2C-2D5E-4415-AA27-965A616C719EQ34185841-9FD71AAF-FF7C-4B2D-877F-4AC979433D55Q34301723-B29F1DBC-919B-4B2F-8AE9-FA88871E1FF2Q34637041-EAE48F25-C8E8-4F2A-959A-9EFC6BCCA4E0Q34796517-D5A4FF40-A72D-4E8D-B830-9BA15C1D1C99Q35081725-221DF74A-DFF4-4FBF-93A4-290E00F033B3Q35088160-C16227E9-1949-46FB-BFE2-40768AB2FE85Q35187451-77450283-7227-4CB3-A686-0167CED378AAQ35800805-0986BFBB-E795-4E92-B2EC-ECC20337B8CAQ35834337-F6B72406-55D1-43D4-A8BF-485B991E6B16Q36655162-D36C5784-426A-4BF1-AFC5-09D556B614B9Q37277510-33A0DB14-7B46-43F2-9D8A-E010EE720AB2Q37378521-56E19BBB-0584-4646-94E7-7A191FF03154Q39836658-19CFE3D9-17F7-48F3-9092-77D6BF714C23Q41613066-4B7B7390-43B7-4D89-B1A1-0FEECB8967BAQ41672909-886CC31D-AB95-42E2-A8B2-3432C33CF368Q41684827-DAFD51CD-02E1-425A-9857-4002DAD0F1CBQ41711512-816D5291-0147-4D9C-B74B-F1FED07148BFQ42263442-92ADAF61-77E8-45DF-8DE9-150F594E5631Q44243169-0D3B40C8-C18D-4924-8501-F7B701377CE3Q44950484-9250C0BA-AB62-4CFF-998C-77A5CEEC228DQ45855298-674027D5-500F-4723-908C-0DF2B4315738Q45868991-4A3575B6-3328-4527-964C-447FD7378768Q45876110-2C62197F-E781-4FEA-ADE0-74357D5ADF78Q45884960-A7EA3B2D-0142-45BB-909A-D0760866C513Q56830832-BC939F36-ADB3-4078-9186-D22CD3D690DD
P2860
Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Importance of age at infection ...... entre Directors' Organisation.
@en
type
label
Importance of age at infection ...... entre Directors' Organisation.
@en
prefLabel
Importance of age at infection ...... entre Directors' Organisation.
@en
P2093
P1433
P1476
Importance of age at infection ...... entre Directors' Organisation.
@en
P2093
P L Giangrande
R J Spooner
P304
P356
10.1016/S0140-6736(96)91073-9
P407
P577
1996-06-01T00:00:00Z